Skip to content

Clinical trials

Glomerulosclerosis, Focal Segmental trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulosclerosis, Focal Segmental Country / region: Italy Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20141
20183
20212
20221
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Completed4
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Travere Therapeutics, Inc.3
Amgen1
Boehringer Ingelheim1
Dimerix Bioscience Pty Ltd1
Genzyme, a Sanofi Company1
Mario Negri Institute for Pharmacological Research1
Meyer Children's Hospital IRCCS1
Novartis Pharmaceuticals1
Pfizer1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulosclerosis, Focal Segmental12
Nephrosis, Lipoid4
Glomerulonephritis, IGA2
Nephritis, Hereditary2
Nephrotic Syndrome2
Diabetic Nephropathies1
Disease1
IgA Vasculitis1
Kidney Diseases1
Proteinuria1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.